Latest News

 Filter by Provider

The Fed will be dealing with the worst of both worlds. Tariff-induced inflation and tariff-induced decline in national output.

Highlighting the uncertainty that hangs over the US economy, first-quarter GDP nowcasts from two regional Fed banks report sharply different estimates.

The spot level of VIX is truly inverted vis-à-vis the futures, but the overall curve is largely flattish.

Investor sentiment was shocked by Trump's 25% tariff on auto imports, increasing inflation fears. But some ETFs performed well, with gains up to 22.8%.

The Westwood LBRTY Global Equity ETF enables investors to overcome risks linked with economically unstable and corrupt regimes.

Cryptocurrency markets are trading in a tight sideways range on Monday as markets expect the impact of tariff announcements on Wednesday.

ETFs classified as Equity U.S. held 26.83% of the overall assets under management at the end of December 2024.

With tariffs coming for more countries in various amounts, a new tool from UPS could help global consumers know the increased prices better.

Sabra Healthcare REIT stock now clears the 80 or higher Relative Strength Rating threshold, with a jump from 78 to 82 Monday.

Goldman Sachs analyst shares key takeaways from 2025 Shoptalk Conference, highlighting conversational and personalized eCommerce, critical video content, and the role of AI in improving brand experience.

Investors should prepare for a 2008-style crisis.Benzinga warns of potential economic crisis predicted by Peter Schiff in 2008. Tariffs, rising interest rates, misguided Fed policy may cause trouble.

Vertex halts VX-264 trials after missing efficacy goals but continues advancing zimislecel, a potential treatment for severe type 1 diabetes, toward approval.

In a welcome move, Stryker stock saw its Relative Strength Rating improve to 72 on Monday, up from 69 a day earlier.

Corcept's ROSELLA trial met its primary endpoint, showing relacorilant improved progression-free and overall survival in platinum-resistant ovarian cancer.

NNOX earnings call for the period ending December 31, 2024.

In today's session, these stocks are experiencing unusual volume.

Virax Biolabs' T-cell testing platform targets post-viral syndromes like Long COVID. HC Wainwright sees a major market opportunity, setting a $3 price target.

Allspring Global Investments launched two new actively managed ETFs (AGR, ASLV) to provide investors with access to mispriced stocks and value ideas.

Investors continue to brace for volatility ahead of U.S. President Donald Trump's tariff announcement this week. Fundstrat's Tom Lee believes bullish traders will get rewarded.

Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) jumped 94.9% in the afternoon session after the company announced that its Phase 3 trial (ROSELLA) met its goal of improving progression-free survival and overall survival in treating resistant ovarian cancer with a new therapy (a combination of Relacorilant and Nab-paclitaxel). 

The Trump family has significantly increased its control over World Liberty Financial, a decentralized finance platform still under development.

Bonds rallied and yields fell not because of inflation and certainly not because of tariffs. It goes back to the growth scare.

A Congressman who bought shares of a Bitcoin (CRYPTO: BTC) ETF before President Donald Trump announced an Executi

Gold prices exceeded $3,000/oz, with potential to reach $3,500 if investment demand rises. China's insurance sector and central banks may increase gold holdings, while ETF inflows signal growing retail interest. Trade policy uncertainty and a weaker U.S. dollar could further support prices.

Hedge funds are rapidly reducing their investments in global technology stocks, particularly in the semiconductor industry.

The energy sector has been running the table year-to-date. Interestingly, the price of crude oil hasn’t participated much in this rally with the energy sector.

On March 27, Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google introduced several new features across Search, Maps, and Gemini